The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.
about
Non-coding landscapes of colorectal cancerPrognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-AnalysisAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort.MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?MicroRNAome genome: a treasure for cancer diagnosis and therapy.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.Colorectal cancer carcinogenesis: a review of mechanismsPrognostic significance of miR-126 in various cancers: a meta-analysis.Identification of serum microRNA profiles in colon cancerMicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trialEvaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum.miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.MicroRNA dysregulation as a prognostic biomarker in colorectal cancerMicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaThe crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A.Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy.Prognostic value of microRNAs in colorectal cancer: a meta-analysis.MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
P2860
Q26778014-75737169-A6BB-476D-8240-1F8C3B97D6EFQ26782492-71E2600D-9C89-46CA-8EDC-1516566F6B57Q27024427-960D81A9-D73D-405F-9721-11CE5F91B075Q34239837-8BA3E818-D695-4093-9CD8-5E4AFB308AD4Q34382704-2F574D99-CC30-4DB6-A730-BF054E421E4DQ34626744-83B3A1B3-4E94-4356-8865-7AF77BB46AC3Q34996343-1314D702-CEAE-4D89-8C5D-0BE3C947A6E6Q35098328-1946B004-7060-4377-9B48-98B251FADEB8Q35190111-C8EB1842-E8D9-4BC0-AB71-AB70B591C227Q35704188-26C23F85-76D5-4BA7-8E16-C9A23A076831Q35811250-05BDB090-81D9-4A7F-A3CA-668A306527A8Q35857777-2E560769-5E5A-43FD-BCB1-0CF802B6FF8BQ36849645-04B5FAAF-60F7-48C1-9C97-399105AF9114Q36858228-61FFAFF2-E622-4924-AFE8-EDC89FCA19ADQ36889636-6A8B5C2C-C0B8-48D7-9EBF-FB147019D6AFQ37185814-8E648DD9-53E9-4C83-B3D8-4C3A4C28268FQ37581936-DED9502B-F140-4B86-BED0-CDD65727934DQ38059508-8000456D-001C-4700-9666-94B8E8F3C9A3Q38247982-C7362EB4-A5D3-488A-9B8D-17B9D9FF219FQ38262497-DD9DFFAD-337E-4812-AD62-BF2E49509E5CQ38552402-65E87B7F-7F44-485F-B050-BE4311DF8BE5Q38697130-9D4405C6-408B-4F03-AA47-AF7E3B71E3C4Q38826542-3E91D082-2DD6-43EA-A6CC-111EEB67BF78Q39390383-145B02BC-0489-4A86-8361-3BEFDBC1D903Q41134824-35995C0E-E90A-45D0-AC17-57EA96811BC3Q41883434-884EEF0A-96FC-412E-83D0-6B51E1A12535Q42128295-43640F33-F567-4B73-96F2-26B52C95045FQ45808925-A40D24B5-E7F7-4C34-BE0D-554555AF0B09Q52647623-3746FFC7-FF42-4099-B1F0-963E81662448Q55307845-F04275F2-C045-4868-9ED4-CC705AEFF7D0Q55439547-E8B3306E-3F0F-4D81-889F-E881777C0539
P2860
The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The predictive value of microR ...... metastatic colorectal cancer.
@ast
The predictive value of microR ...... metastatic colorectal cancer.
@en
type
label
The predictive value of microR ...... metastatic colorectal cancer.
@ast
The predictive value of microR ...... metastatic colorectal cancer.
@en
prefLabel
The predictive value of microR ...... metastatic colorectal cancer.
@ast
The predictive value of microR ...... metastatic colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
The predictive value of microR ...... h metastatic colorectal cancer
@en
P2093
Anders Jakobsen
Flemming Brandt Sørensen
Jan Lindebjerg
P2860
P2888
P356
10.1186/1471-2407-12-83
P407
P577
2012-03-08T00:00:00Z
P5875
P6179
1042893808